170 related articles for article (PubMed ID: 35441348)
1. Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer.
Mercer-Smith AR; Buckley A; Valdivia A; Jiang W; Thang M; Bell N; Kumar RJ; Bomba HN; Woodell AS; Luo J; Floyd SR; Hingtgen SD
Stem Cell Rev Rep; 2022 Oct; 18(7):2474-2493. PubMed ID: 35441348
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X; Cheung RM; Komaki R; Fang B; Chang JY
Clin Cancer Res; 2005 Sep; 11(18):6657-68. PubMed ID: 16166445
[TBL] [Abstract][Full Text] [Related]
3. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.
Voortman J; Resende TP; Abou El Hassan MA; Giaccone G; Kruyt FA
Mol Cancer Ther; 2007 Jul; 6(7):2103-12. PubMed ID: 17620439
[TBL] [Abstract][Full Text] [Related]
4. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
5. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
6. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer.
Mercer-Smith AR; Jiang W; Bago JR; Valdivia A; Thang M; Woodell AS; Montgomery SA; Sheets KT; Anders CK; Hingtgen SD
Mol Cancer Ther; 2021 Nov; 20(11):2291-2301. PubMed ID: 34433662
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated TRAIL expression and downregulation of Bcl-2 expression suppresses non-small cell lung cancer growth in vitro and in vivo.
Zhang H; Sui A; Wang Z; Liu S; Yao R
Int J Mol Med; 2012 Aug; 30(2):358-64. PubMed ID: 22614533
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil preferentially sensitizes mutant KRAS non-small cell lung carcinoma cells to TRAIL-induced apoptosis.
Wang H; Yang T; Wu X
Mol Oncol; 2015 Nov; 9(9):1815-24. PubMed ID: 26130327
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells.
De Miguel D; Gallego-Lleyda A; Ayuso JM; Erviti-Ardanaz S; Pazo-Cid R; del Agua C; Fernández LJ; Ochoa I; Anel A; Martinez-Lostao L
Nanotechnology; 2016 May; 27(18):185101. PubMed ID: 27001952
[TBL] [Abstract][Full Text] [Related]
11. Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers.
Jiang W; Yang Y; Mercer-Smith AR; Valdivia A; Bago JR; Woodell AS; Buckley AA; Marand MH; Qian L; Anders CK; Hingtgen SD
Sci Adv; 2021 Jun; 7(24):. PubMed ID: 34108203
[TBL] [Abstract][Full Text] [Related]
12. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
13. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.
Zhuang H; Jiang W; Zhang X; Qiu F; Gan Z; Cheng W; Zhang J; Guan S; Tang B; Huang Q; Wu X; Huang X; Jiang W; Hu Q; Lu M; Hua ZC
J Mol Med (Berl); 2013 Feb; 91(2):219-35. PubMed ID: 22948392
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
15. A role for TRAIL/TRAIL-R2 in radiation-induced apoptosis and radiation-induced bystander response of human neural stem cells.
Ivanov VN; Hei TK
Apoptosis; 2014 Mar; 19(3):399-413. PubMed ID: 24158598
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin.
Li X; You M; Liu YJ; Ma L; Jin PP; Zhou R; Zhang ZX; Hua B; Ji XJ; Cheng XY; Yin F; Chen Y; Yin W
Sci Rep; 2017 Feb; 7():42748. PubMed ID: 28209994
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
19. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.
Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Qian Y; Zhang L; Ma H; Jiang X
Int J Nanomedicine; 2012; 7():1449-60. PubMed ID: 22619505
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Tian S; Liu DH; Wang D; Ren F; Xia P
Cell Physiol Biochem; 2018; 51(1):217-227. PubMed ID: 30448845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
